http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109464406-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89e701f761759a3d745e79115cd78ad7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 |
| filingDate | 2018-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d838bbf51568e18fbc3eaee0b10021b |
| publicationDate | 2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109464406-A |
| titleOfInvention | 2mg loperamide hydrochloride tablet technology |
| abstract | The invention discloses a process for 2 mg loperamide hydrochloride tablets, which is characterized by comprising the following steps: S1, taking loperamide hydrochloride, Ludipress and magnesium stearate materials respectively, and screening them with a stainless steel sieve; S2, taking The sieved magnesium stearate is added into the mixer, and the mixer is turned on; S3, take out the magnesium stearate, add the mixture of loperamide hydrochloride and 10kg Ludipress in the mixer to mix; S4, add the remaining sieved S5, add magnesium stearate to mix; S6, take out the mixed material, add it into a tablet press, and perform tableting; S7, obtain semi-finished products, inspect, and package to obtain finished products. In the present invention, the process technology, quality management and quality control, material balance and consumption, sanitation, safety, environmental protection and other contents of the whole process of production of 2mg loperamide hydrochloride tablets are produced according to the requirements of the licensed product and are in line with the drug license. Certificate and GMP requirements, so that the stability, safety, reliability and consistency of product quality can be guaranteed. |
| priorityDate | 2018-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.